Coloplast A/S Stock

Coloplast A/S EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Coloplast A/S (COLO B.CO) as of Aug 1, 2026 is 8.48 B DKK. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 8.07 B DKK — a change of 5.07% (higher).

EBITDA

8.48 BDKK

YoY

5.07%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Coloplast A/S is 2026 8.48 B DKK. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Coloplast A/S was 2025 8.07 B DKK. It decreases by 5.07% higher compared to the previous year.
Access this data via the Eulerpool API

Coloplast A/S Stock analysis

What does Coloplast A/S do? Coloplast A/S is a Danish company that has been manufacturing products for people with stoma, incontinence, and wound care needs since 1957. The company's headquarters is located in Humlebæk, Denmark, and it employs over 12,000 employees worldwide. Translated: Coloplast A/S is a Danish company that has been manufacturing products for people with stoma, incontinence, and wound care needs since 1957. The company's headquarters is located in Humlebæk, Denmark, and it employs over 12,000 employees worldwide. Coloplast A/S is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Coloplast A/S stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Coloplast A/S is 8.48 B DKK in 2026.

Access this data via the Eulerpool API

Income Statement — Coloplast A/S

All Key Metrics — Coloplast A/S